1-5 of 5
Helena Hohtari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity

Olli Dufva, Jan Koski, Pilvi Maliniemi, Aleksandr Ianevski, Jay Klievink, Judith Leitner, Petri Pölönen, Helena Hohtari, Khalid Saeed, Tiina Hannunen, Pekka Ellonen, Peter Steinberger, Matti Kankainen, Tero Aittokallio, Mikko A. I. Keränen, Matti Korhonen, Satu Mustjoki
Journal: Blood
Blood (2020) 135 (9): 597–609.
https://doi.org/10.1182/blood.2019002121
Published: 2020
Includes: Supplemental data
Journal Articles

BCR-ABL1 p190 in CML: A Minor Breakpoint with a Major Impact

Shady Adnan Awad, MD, Helena Hohtari, MD, Komal Kumar Javarappa, PhD, Tania Brandstoetter, Daehong Kim, Swapnil Potdar, MSc, Caroline A Heckman, PhD, Soili Kytölä, PhD, Kimmo Porkka, Eszter Doma, PhD, Veronika Sexl, MD PhD, Matti Kankainen, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 190.
https://doi.org/10.1182/blood-2019-126584
Published: 2019
Journal Articles

Targeting BCL-2, BCL-XL, BCL-W and MDM2 in B-Cell Acute Lymphoblastic Leukemia Is Highly Effective Ex Vivo

Helena Hohtari, MD, Shady Awad, MD, Olli Dufva, Swapnil Potdar, MSc, Caroline A Heckman, PhD, Krister Wennerberg, PhD, Satu Mustjoki, MD PhD, Kimmo Porkka, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3975.
https://doi.org/10.1182/blood-2018-99-110610
Published: 2018
Journal Articles

High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia

Helena Hohtari, MD, Oscar Brück, Sami Blom, MSc, Riku Turkki, MSc, Antonio Ribeiro, BSc, Marjatta Sinisalo, MD PhD, Panu Kovanen, MD PhD, Olli Kallioniemi, MD PhD, Teijo Pellinen, PhD, Kimmo Porkka, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3985.
https://doi.org/10.1182/blood.V130.Suppl_1.3985.3985
Published: 2017
Journal Articles

Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia

Helena Hohtari, MD, Marjatta Sinisalo, Tapio Nousiainen, MD PhD, Perttu Koskenvesa, MD, Ulla Wartiovaara-Kautto, MD PhD, Satu Mustjoki, MD PhD, Pirjo Koistinen, MD PhD, Marjaana Säily, MD PhD, Maija Itälä-Remes, Erkki Elonen, MD PhD, Kari Remes, MD PhD, Kimmo Porkka, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1598.
https://doi.org/10.1182/blood.V128.22.1598.1598
Published: 2016